E
Petros Pharmaceuticals, Inc. PTPI
$0.028 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- 299.12% -5.87% -28.71%
Total Other Revenue -- -- -- -- --
Total Revenue -- -- 299.12% -5.87% -28.71%
Cost of Revenue -- -- 67.49% -29.74% --
Gross Profit -- -- 188.17% 1.83% --
SG&A Expenses 33.48% -2.97% -49.65% 14.96% -40.03%
Depreciation & Amortization -- -- -18.25% -10.57% --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 33.48% -2.97% -47.11% 7.99% -69.73%
Operating Income -33.48% 2.97% 65.33% -19.89% 45.22%
Income Before Tax -631.17% -413.27% -3,014.33% 51.19% 115.09%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -631.17% -413.27% -3,014.33% 51.19% 115.09%
Earnings from Discontinued Operations 814.34% 58.34% -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 920.66% -4.50% -3,014.33% 51.19% 74.01%
EBIT -33.48% 2.97% 65.33% -19.89% 45.22%
EBITDA -73.13% 4.41% 74.24% -42.27% 61.41%
EPS Basic 86.05% 77.78% 33.91% 81.28% 69.22%
Normalized Basic EPS -106.05% -151.31% -566.32% 89.47% 104.32%
EPS Diluted 86.05% 77.78% 33.91% 81.28% 69.22%
Normalized Diluted EPS -106.05% -151.31% -566.32% 89.47% 104.32%
Average Basic Shares Outstanding 8,672.42% 510.51% 325.13% 363.68% 248.88%
Average Diluted Shares Outstanding 8,672.42% 510.51% 325.13% 363.68% 248.88%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --